BÜHLMANN is the world’s EXPERT for CALPROTECTIN.The BÜHLMANN fCAL® turbo assay, for clinical chemistry analysers, measures in a range of 20 to 8,000 µg/g. The unique CALEX® stool extraction device allows for a clean, precise and easy sample collection and stabilization over time. BÜHLMANN fCAL® is available also as ELISA and rapid tests for POC and home diagnostics. The Quantum Blue® Infliximab and Adalimumab rapid tests for therapeutic drug monitoring, complement the BÜHLMANN solution offer for patients affected by an Inflammatory Bowel Disease. Other key areas are neuroimmunology, with the BÜHLMANN GanglioCombi™ MAG ELISA, and allergy, with the Flow CAST® Basophil Activation Test, on top of routine diagnostics tests such as ACE, High Sensitive ACE and GHB. BÜHLMANN is a fully independent, globally active company based in Switzerland.